87 related articles for article (PubMed ID: 2023705)
1. Low uracil concentration in the liver might be responsible for the decreased antineoplastic activity of fluoropyrimidines in mice with CCl4-induced chronic liver dysfunction.
Tsubono M; Nio Y; Imai S; Shiraishi T; Morimoto H; Tseng CC; Kawabata K; Fukumoto M; Tobe T
Oncology; 1991; 48(3):246-52. PubMed ID: 2023705
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy with fluoropyrimidines for MOPC-104E plasmacytoma transplanted in mice with CCl4 induced chronic liver dysfunction].
Tsubono M; Nio Y; Imai S; Shiraishi T; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):640-7. PubMed ID: 2141051
[TBL] [Abstract][Full Text] [Related]
3. Relationship of in vivo antitumor activities of fluorinated pyrimidines to thymidylate synthase activity and intratumoral concentrations of 5-fluorouracil and uracil.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Imai S; Tobe T
Anticancer Res; 1991; 11(2):607-12. PubMed ID: 2064315
[TBL] [Abstract][Full Text] [Related]
4. [Anti-tumor effect of fluoropyrimidines on human tumor cell lines transplanted in nude mice with CCl4-induced liver dysfunction].
Nio Y; Imai S; Shiraishi T; Ohgaki K; Tobe T
Nihon Geka Gakkai Zasshi; 1989 Apr; 90(4):538-45. PubMed ID: 2503704
[TBL] [Abstract][Full Text] [Related]
5. [Effect of fluoropyrimidine, drugs of tegafur and UFT on transplanted tumor in liver-damaged mice].
Aoike A; Hosokawa T; Koyama K; Rokutan K; Nishi Y; Yoshida A; Nakamura K; Kawai K
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2899-905. PubMed ID: 3140731
[TBL] [Abstract][Full Text] [Related]
6. The antitumor effect of hyperthermia combined with fluorouracil and its analogues.
Harada S; Ping L; Obara T; Oikawa H; Miyata M; Matsuo M; Takahashi T; Yanagisawa T
Radiat Res; 1995 May; 142(2):232-41. PubMed ID: 7724740
[TBL] [Abstract][Full Text] [Related]
7. Effect of dimethylnitrosamine-induced liver dysfunction on the pharmacokinetics of 5-fluorouracil after administration of S-1, an antitumour drug, to rats.
Yoshisue K; Kanie S; Nishimura T; Chikamoto J; Nagayama S
J Pharm Pharmacol; 2009 Dec; 61(12):1643-51. PubMed ID: 19958587
[TBL] [Abstract][Full Text] [Related]
8. Effect of coadministration of thymine or thymidine on the antitumor activity of 1-(2-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil.
Fujii S; Kitano S; Ikenaka K; Fukushima M; Nakamura H; Maehara Y; Shirasaka T
Gan; 1980 Feb; 71(1):100-6. PubMed ID: 6769735
[TBL] [Abstract][Full Text] [Related]
9. Effect of coadministration of uracil or cytosine on the anti-tumor activity of clinical doses of 1-(2-tetrahydrofuryl)-5-fluorouracil and level of 5-fluorouracil in rodents.
Fujii S; Kitano S; Ikenaka K; Shirasaka T
Gan; 1979 Apr; 70(2):209-14. PubMed ID: 381088
[TBL] [Abstract][Full Text] [Related]
10. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics of fluoropyrimidines].
Fujita H
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2307-15. PubMed ID: 6437341
[TBL] [Abstract][Full Text] [Related]
12. Studies on the metabolism of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil co-administered orally to tumor-bearing rats.
Kawaguchi Y; Nagayama S; Masuda H; Yasuda A
Gan; 1980 Dec; 71(6):889-99. PubMed ID: 6791982
[TBL] [Abstract][Full Text] [Related]
13. Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts.
Takechi T; Okabe H; Ikeda K; Fujioka A; Nakagawa F; Ohshimo H; Kitazato K; Fukushima M
Oncol Rep; 2005 Jul; 14(1):33-9. PubMed ID: 15944764
[TBL] [Abstract][Full Text] [Related]
14. A new method for the evaluation of the liver injury by 19F MRS of 5-fluorouracil.
Harada M; Koga K; Miura I; Nishitani H
Magn Reson Med; 1991 Dec; 22(2):499-504. PubMed ID: 1812383
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of tegafur in rat liver observed by in vivo 19F magnetic resonance spectroscopy and chromatography.
Harada M; Nishitani H; Koga K; Miura I; Umeno Y
Jpn J Cancer Res; 1992 Apr; 83(4):387-91. PubMed ID: 1506273
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
17. [Tegafur and 5-FU concentrations in cancerous and normal tissues in nude mice after oral administration of UFT].
Murahashi I; Honda M; Mukae K; Hosoya Y; Takasaki E
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3265-9. PubMed ID: 3120643
[TBL] [Abstract][Full Text] [Related]
18. Effect of carbon tetrachloride intoxication and ethanol ingestion on interferon production in mice.
Daniluk J; Chibowski D; Szuster-Ciesielska A; Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 1994; 42(4):325-30. PubMed ID: 7487375
[TBL] [Abstract][Full Text] [Related]
19. [5-Fluorouracil, tegafur, and uracil concentrations in serum and tissue of the patients with hepatocellular carcinoma after UFT administration].
Suenaga M
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3313-8. PubMed ID: 2825604
[TBL] [Abstract][Full Text] [Related]
20. Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.
Ikeda K; Yoshisue K; Matsushima E; Nagayama S; Kobayashi K; Tyson CA; Chiba K; Kawaguchi Y
Clin Cancer Res; 2000 Nov; 6(11):4409-15. PubMed ID: 11106261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
